Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Tiberghien

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 11, 2019
The best blood product and its best use for each patient: An evolving role for hemovigilance?Pierre Tiberghien
Transplantation|January 26, 2002
Dendritic cells: to where do they lead?Philippe Saas, Pierre Tiberghien
Presse Medicale (Paris, France : 1983)|January 13, 2015
[Blood transfusion: the challenges for tomorrow?]Gilles Folléa, Olivier Garraud, Pierre Tiberghien
Transplantation|February 9, 2005
B Cell allogeneic responses after hematopoietic cell transplantation: is it time to address this issue?Sylvain Perruche, François Kleinclauss, Pierre Tiberghien, et al.
Expert Opinion on Biological Therapy|March 14, 2002
Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance inductionPhilippe Saas, Pierre Tiberghien, Marcelo de Carvalho Bittencourt
Transfusion Medicine (Oxford, England)|January 12, 2022
The impact of pathogen-reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trialFrédéric Garban, Antoine Vilotitch, Pierre Tiberghien, et al.
Bulletin Du Cancer|November 12, 2003
[Allorecognition of the recipient after hematopoietic transplantation]Pierre Tiberghien, Eric Robinet, Christophe Ferrand, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2010
Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHDLaurent Mailly, Céline Leboeuf, Pierre Tiberghien, et al.
Transplantation|June 24, 2003
Administration of donor apoptotic cells: an alternative cell-based therapy to induce tolerance?François Kleinclauss, Sylvain Perruche, Jean-Yves Cahn, et al.
Cardiovascular Research|January 11, 2005
Can stem cells mend a broken heart?Siamak Davani, Frédéric Deschaseaux, David Chalmers, et al.
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 11, 2019
The best blood product and its best use for each patient: An evolving role for hemovigilance?Pierre Tiberghien
Transplantation|January 26, 2002
Dendritic cells: to where do they lead?Philippe Saas, Pierre Tiberghien
Presse Medicale (Paris, France : 1983)|January 13, 2015
[Blood transfusion: the challenges for tomorrow?]Gilles Folléa, Olivier Garraud, Pierre Tiberghien
Transplantation|February 9, 2005
B Cell allogeneic responses after hematopoietic cell transplantation: is it time to address this issue?Sylvain Perruche, François Kleinclauss, Pierre Tiberghien, et al.
Expert Opinion on Biological Therapy|March 14, 2002
Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance inductionPhilippe Saas, Pierre Tiberghien, Marcelo de Carvalho Bittencourt
Transfusion Medicine (Oxford, England)|January 12, 2022
The impact of pathogen-reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trialFrédéric Garban, Antoine Vilotitch, Pierre Tiberghien, et al.
Bulletin Du Cancer|November 12, 2003
[Allorecognition of the recipient after hematopoietic transplantation]Pierre Tiberghien, Eric Robinet, Christophe Ferrand, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2010
Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHDLaurent Mailly, Céline Leboeuf, Pierre Tiberghien, et al.
Transplantation|June 24, 2003
Administration of donor apoptotic cells: an alternative cell-based therapy to induce tolerance?François Kleinclauss, Sylvain Perruche, Jean-Yves Cahn, et al.
Cardiovascular Research|January 11, 2005
Can stem cells mend a broken heart?Siamak Davani, Frédéric Deschaseaux, David Chalmers, et al.
Pageof 19